Sep 12, 2022 | All Posts, Main Blog, Medical Device |
For healthcare marketers, reaching and engaging today’s busy physicians and C-suite executives is more challenging than ever – especially during and post COVID-19. According to the a recent Survey of America’s Physicians, they, are so busy they have no time to...
Oct 8, 2021 | All Posts, Controlled Release, Drug Bioavailability, Peptide |
Nanomedicines continue to accelerate the forefront of drug delivery technologies. Inorganic mesoporous silica nanoparticles are a driving force with their unique and superlative properties. Recently, formulation researches with mesoporous silica nanoparticles have...
Jul 7, 2021 | All Posts, Controlled Release, Drug Bioavailability, Main Blog, Peptide |
A prodrug is a medication or compound that metabolizes into a pharmacologically active drug after administration, offering opportunities to optimize the pharmaceutical property to improve bioavailability. Approximately 10% of all marketed drugs worldwide can be...
Mar 13, 2021 | All Posts, Controlled Release, Drug Bioavailability, Main Blog, Peptide |
Given the rise of peptide and protein therapeutics in the pharmaceutical landscape, identifying the right delivery strategies that are patient-friendly and can be used over broad dose ranges has always been important considerations for the discovery and development of...
Mar 6, 2021 | All Posts, BioPharma Marketing, Main Blog, Medical Device |
Beyond the Pill: Sanofi’s Approach to Digital Therapeutics & Driving Improved Outcomes for Patients “In the context of the COVID-19 public health emergency, the use of digital health technologies, including software as a medical device or other digital...
Dec 13, 2020 | All Posts, Reputation |
As the US starts rolling out vaccines in a matter of days around the country, pharma brands are already preparing themselves to combat the surge in disinformation threatening patient adoption and hampering administering and monitoring the vaccine safely, with the...
Recent Comments